Deans' stroke musings: An Investigation into the Clinical Use of Botulinum Toxin Type A to Treat Post-stroke Hemiplegic Patients with Upper and/or Lower Limb Spasticity

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, April 24, 2019

An Investigation into the Clinical Use of Botulinum Toxin Type A to Treat Post-stroke Hemiplegic Patients with Upper and/or Lower Limb Spasticity

You had better hope your doctor does take into consideration your body size. There have been instances of children and small women who have died from botox.

An Investigation into the Clinical Use of Botulinum Toxin Type A to Treat Post-stroke Hemiplegic Patients with Upper and/or Lower Limb Spasticity

上下肢痙縮を有する脳卒中後の片麻痺患者を対象とした A 型ボツリヌス毒素製剤投与状況の調査. The Japanese Journal of Rehabilitation Medicine , Volume 52(7) , Pgs. 421-430.

NARIC Accession Number: I244969. What's this?
Author(s): Akio KIMURA; Masahiro ABO; Yoshihisa MASAKADO; Yoshiyuki YAMASHITA; Toshio MAEDA.
Publication Year: 2015.

Abstract:

The purpose of this study was to investigate the clinical use of botulinum toxin type A (BoNT/A) by physicians with expertise in the treatment of upper and lower limb spasticity in post-stroke patients with spastic hemiplegia. To this end, a multicenter review was conducted of the medical records of 307 Japanese post-stroke patients treated with BoNT/A during the period January 1, 2012 to November 30, 2013. The review provided a variety of information on factors relating to BoNT/A injection outcomes, including the total dose of BoNT/A per treatment session, the dose of BoNT/A per muscle, the number of injection sites per muscle, the method used to locate the muscles to be injected, and the dilution of reconstituted BoNT/A. Review analysis indicated that the dose of BoNT/A administered per muscle was usually selected by taking into consideration the severity of spasticity, rather than the patient’s body size. Since the technical expertise of experienced clinicians is summarized in this review, it may serve as a useful reference for the use of BoNT/A in routine clinical practice.
Descriptor Terms: Hemiplegia, Spasticity, Stroke.
Language: Japanese
Geographic Location(s): Japan, East & Southeast Asia.

Can this document be ordered through NARIC's document delivery service*?: Request Information.
Get this Document: https://www.jstage.jst.go.jp/article/jjrmc/52/7/52_421/_pdf/-char/en.

Citation: Akio KIMURA, Masahiro ABO, Yoshihisa MASAKADO, Yoshiyuki YAMASHITA, Toshio MAEDA. (2015). An Investigation into the Clinical Use of Botulinum Toxin Type A to Treat Post-stroke Hemiplegic Patients with Upper and/or Lower Limb Spasticity. 上下肢痙縮を有する脳卒中後の片麻痺患者を対象とした A 型ボツリヌス毒素製剤投与状況の調査. The Japanese Journal of Rehabilitation Medicine , 52(7), Pgs. 421-430. Retrieved 4/24/2019, from REHABDATA database.